Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Coronavirus Infections

• Xofluza-Wearables Feasibility-Study
• Study of Monoclonal Antibodies for Early Etiotropic Therapy for Coronavirus Infection Caused by the SARS-CoV-2 Virus
• The Application of Ursodeoxycholic Acid for the Prevention of Novel Coronavirus Infections
• Lianhua Qingwen for the Rehabilitation of Patient With Coronavirus Infection
• Lianhua Qingke for the Rehabilitation of Patient With Omicron Infection
• International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response
• A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19
• Huashi Baidu Granule in the Treatment of Pediatric Patients With Mild Coronavirus Disease 2019
• Effect of Corona Virus on Intravitreal Injections
• Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I
• A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults
• Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers
• Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)
• Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients
• STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care
• A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults
• Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection
• TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation
• Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)
• Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)
• Convalescent Plasma Therapy for Hospitalized Patients With COVID-19
• LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
• A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER-PEDS)
• Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2
• Arformoterol/Budesonide for COVID-19
• Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19
• Masitinib in Patients With Symptomatic Mild to Moderate COVID-19
• Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
• Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2
• Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)
• Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip
• Third Dose of COVID-19 Vaccine in LTCF Residents
• Study of Varespladib in Patients Hospitalized With Severe COVID-19
• Jing-Si-Herbal-Tea Accelerates SARS-Cov-2 Load Reduction Among COVID-19 Patients
• Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients
• Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)
• Phase 2 Study of RSLV-132 in Subjects With Long COVID
• Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)
• Novel Experimental COVID-19 Therapies Affecting Host Response
• Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19
• Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction
• Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
• Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019
• A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia
• Effectiveness of Colchicine Among Patients With COVID-19 Infection
• SARS-CoV-2 Human Challenge Characterisation Study
• Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia
• Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit
• Quercetin In The Treatment Of SARS-COV 2
• Proxalutamide Treatment for COVID-19 Female Outpatients
• The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)
• A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients
• Covid-19, Hospitalized, PatIents, Nasafytol
• VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study
• Efficacy of Ivermectin in Outpatients With Non-severe COVID-19
• Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19
• EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19
• Imaging Immune Activation in COVID-19
• Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
• The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
• Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients
• Ivermectin Reproposing for Mild Stage COVID-19 Outpatients
• Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients
• Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
• COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications
• Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19
• Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19
• Annexin A5 in Patients With Severe COVID-19 Disease
• COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study
• Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19
• A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)
• The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection
• Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19
• The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients
• The DAWN Camostat Trial for Ambulatory COVID-19 Patients
• Proxalutamide Treatment for Hospitalized COVID-19 Patients
• Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms
• Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome
• Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva
• Fluvoxamine for Adults With Mild to Moderate COVID-19
• Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)
• Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
• Sargramostim Use in COVID-19 to Recover Patient Health
• Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins
• Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients
• Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)
• Role of Mega Dose of Vitamin C in Critical COVID-19 Patients
• Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals
• COVID-19 Long-Haulers Study
• A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19
• Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients
• Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)
• Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
• Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19
• Camostat With Bicalutamide for COVID-19
• Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts
• Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland
• A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19
• Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)
• Anakinra in the Management of COVID-19 Infection
• Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
• Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)
• Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19
• Use of Angiotensin-(1-7) in COVID-19
• Intravenous Zotatifin in Adults With Mild or Moderate COVID-19
• Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
• Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)
• Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection
• Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2
• Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.
• Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19
• A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19
• Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting
• IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation
• Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia
• Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19)
• Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia
• Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?
• A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19
• Ivermectin in Adults With Severe COVID-19.
• Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients
• Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis
• Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19)
• Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients
• GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)
• Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
• Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers
• Mouth Rinses for Inactivation of COVID-19
• OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 "
• Efficacy of Nicotine in Preventing COVID-19 Infection
• Inflammatory Signal Inhibitors for COVID-19 (MATIS)
• Fostamatinib for Hospitalized Adults With COVID-19
• Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)
• Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)
• GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia
• Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19
• Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)
• Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19
• Nitazoxanide Therapy for Patients With COVID-19 Pneumonia
• COVID-19 Prophylaxis South Africa (COVER HCW)
• Remdesivir in COVID-19 Lahore General Hospital
• Tocilizumab in COVID-19 Lahore General Hospital
• Methylprednisolone in COVID-19 Patients (Methyl19LGH)
• Effects of Early Use of Nitazoxanide in Patients With COVID-19
• Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19
• A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)
• Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)
• A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19
• Impact of Colchicine in Hospitalized Colombian Patients With COVID-19
• COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes
• Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS
• Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients
• Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19
• Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization
• Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
• Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection
• Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19
• High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study
• Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents
• CSL324 in COVID-19
• Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia
• ACTIV-2: A Study for Outpatients With COVID-19
• CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19
• A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)
• Canakinumab in Patients With COVID-19 and Type 2 Diabetes
• COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
• A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection
• Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19
• BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
• Tele-health Enabled Clinical Trial for COVID-19
• Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)
• SPI-1005 Treatment in Moderate COVID-19 Patients
• SPI-1005 Treatment in Severe COVID-19 Patients
• Trial of Combination Therapy to Treat COVID-19 Infection
• Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)
• Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831
• Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)
• Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19
• Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement
• Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19
• Reducing Asymptomatic Infection With Vitamin D in Coronavirus Disease
• Enzalutamide Treatment in COVID-19
• GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study
• Efficacy of Iodine Complex Against COVID-19 Patients
• Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19
• Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients
• Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19
• A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19
• To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients
• This Study Aims to Use Convalescent Plasma as Experimental Treatment in Critically Ill Patients With Covid-19
• Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial
• A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers
• A Study of Combination Therapies to Treat COVID-19 Infection
• Hesperidin and Diosmin for Treatment of COVID-19
• NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection
• Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).
• A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)
• Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection
• Anti-Androgen Treatment for COVID-19
• A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic
• Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection
• A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)
• Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers
• Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19)
• A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19
• A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).
• Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
• BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization
• Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada)
• Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19
• Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
• Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia
• STerOids in COVID-19 Study
• A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19
• Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19
• A Study of Opaganib in Coronavirus Disease 2019 Pneumonia
• Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease
• Intermediate IND Severe Illness COVID-19 CP
• P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19
• Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)
• Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)
• Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide
• Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"
• LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)
• A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
• Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)
• Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial
• Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
• Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.
• Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial
• SINUS WASH Pilot Study in Adults Testing Positive for COVID-19
• A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
• COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers
• COVID-19 and Anti-CD14 Treatment Trial
• Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19
• Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial
• Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus
• COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111
• Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19
• Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19
• Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19
• Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
• Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19
• Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis
• Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19
• Novel Regimens in COVID-19 Treatment
• Inhaled Ibuprofen to Treat COVID-19
• A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19
• Randomised Evaluation of COVID-19 Therapy
• Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19
• Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)
• A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19
• Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)
• A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)
• Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease
• Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury
• Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?
• Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
• Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial
• Early Intervention in COVID-19: Favipiravir Verses Standard Care
• Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19
• Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
• Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers
• A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic
• Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19
• Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome
• Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora
• Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
• Protective Effect of Aspirin on COVID-19 Patients
• Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)
• Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP)
• COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19
• Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)
• Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19
• Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation
• Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
• suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)
• Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation
• Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19
• Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia
• Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)
• Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment
• Trial of Hydroxychloroquine In Covid-19 Kinetics
• Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.
• PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine
• Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)
• Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19
• Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore
• Saved From COVID-19
• Efficacy and Safety of Favipiravir in Management of COVID-19
• Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection
• Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.
• Honey & Nigella Sativa Trial Against COVID-19
• Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)
• Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds
• Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)
• Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
• COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial)
• Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19
• Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
• A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection
• Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
• University of Utah COVID-19 Hydrochloroquine Trial
• Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19
• Effects of DPP4 Inhibition on COVID-19
• Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection
• CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection
• Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19
• Will Hydroxychloroquine Impede or Prevent COVID-19
• Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)
• Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection
• Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction
• Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection
• Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers
• A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection
• Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)
• Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care
• Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel
• LIBERATE Trial in COVID-19
• A Study of Quintuple Therapy to Treat COVID-19 Infection
• Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019
• Treatment of SARS Caused by COVID-19 With Ruxolitinib
• Hydroxychloroquine in Outpatient Adults With COVID-19
• Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive
• Piclidenoson for Treatment of COVID-19
• Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease
• Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study
• Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
• Convalescent Plasma for Patients With COVID-19: A Pilot Study
• CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)
• Coronavirus (COVID-19) ACEi/ARB Investigation
• EPICOS Clinical Trial for the Prevention of Infection in Healthcare Personnel
• Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)
• Pre-exposure Prophylaxis for SARS-Coronavirus-2
• COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III
• Sarilumab COVID-19
• BCG Vaccination to Protect Healthcare Workers Against COVID-19
• The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention
• ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection
• Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
• Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease
• A Study of a Candidate COVID-19 Vaccine (COV001)
• Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial
• Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI
• Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
• Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2
• Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
• Colchicine Counteracting Inflammation in COVID-19 Pneumonia
• Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19
• Escin in Patients With Covid-19 Infection
• Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)
• Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
• The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
• Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)
• COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir
• The Impact of Camostat Mesilate on COVID-19 Infection
• Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff
• Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia
• Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)
• Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial)
• CD24Fc (MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)
• Norwegian Coronavirus Disease 2019 Study
• Trial of Treatments for COVID-19 in Hospitalized Adults
• Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial)
• NO Prevention of COVID-19 for Healthcare Providers
• Losartan for Patients With COVID-19 Requiring Hospitalization
• Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
• Losartan for Patients With COVID-19 Not Requiring Hospitalization
• Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019
• Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2
• Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)
• Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19
• Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting
• Fight COVID-19 Trial
• Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)
• Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients
• Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
• Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.
• Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection
• The Clinical Study of Carrimycin on Treatment Patients With COVID-19
• The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19
• A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
• Adaptive COVID-19 Treatment Trial (ACTT)
• Fingolimod in COVID-19
• Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment
• Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia
• Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia
• Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)
• Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19
• Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection
• Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19
• The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection
• Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19
• A Randomized Multicenter Controlled Clinical Trial of Arbidol in Patients With 2019 Novel Coronavirus (2019-nCoV)
• Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure
• Study of Safety and Immunogenicity of BVRS-GamVac-Combi
• Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19
• Lessening Organ Dysfunction With VITamin C
• Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS
• Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections
• MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
• A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
• SARS Coronavirus Vaccine (SARS-CoV)
• Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers
• Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)